venBio Partners LLC reported 7 holdings worth US$519M as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 14, 2026
venBio Partners LLC reported 7 holdings worth US$519M as of Jun 30, 2026. Largest: Parabilis Medicines, Inc., Alumis Inc. and Achieve Life Sciences, Inc. Filed Aug 14, 2026 (Form 13F).
- Holdings
- 7
- Value as reported
- US$519M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Parabilis Medicines, Inc. | 5.27M | US$144M | 27.8% |
| Alumis Inc. | 4.53M | US$127M | 24.5% |
| Achieve Life Sciences, Inc. | 5.91M | US$38.6M | 7.4% |
| Alx Oncology Holdings Inc. | 12.9M | US$26.7M | 5.1% |
| Harmony Biosciences Holdings, Inc. | 472K | US$17.2M | 3.3% |
| Lyell Immunopharma, Inc. | 338K | US$4.74M | 0.91% |
| Artiva Biotherapeutics, Inc. | 0 | US$0 | 0.00% |